Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Fruchart

Showing results (391-400 of 538) with videos related to

Pageof 54
Sort By:
Circulation|February 24, 2001
PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophagesB P Neve, D Corseaux, G Chinetti, et al.
Metabolism: Clinical and Experimental|December 1, 1991
High-density lipoprotein particles in octogenariansG Luc, J M Bard, S Lussier-Cacan, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 14, 1990
Lipoprotein particles in homozygous familial hypercholesterolemic patients treated with portacaval shunt and LDL apheresisD Gairin, F Monard, C Cachera, et al.
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1991
[Liaison of apolipoprotein A with adipose cells: characteristics of the receptor sites and their role in the efflux of cholesterol]R Barbaras, P Puchois, A Pradines-Figuères, et al.
Presse Medicale (Paris, France : 1983)|December 17, 1988
[Type IIa dyslipoproteinemia. Effects of simvastatin and bezafibrate on atherogenic and non-atherogenic lipoprotein particles]J M Lecerf, J M Bard, V Leclerc, et al.
Clinical Chemistry|June 1, 1987
Electroimmunoassay for determination of ApoB in human sera by using a mixture of monoclonal antibodiesI Pruvot, C Fievet, J C Fruchart, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1987
Chemical approach to synthetic immunogens in clinical chemistryC Delpierre, C Martin, J C Gesquiere, et al.
Circulation Research|September 4, 1999
Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathwayP Delerive, F Martin-Nizard, G Chinetti, et al.
Revue D'Epidemiologie Et De Sante Publique|April 10, 2003
[Biological banks of the prospective cohort PRIME Study]G Luc, J Ferri res, A Evans, et al.
Biochimica Et Biophysica Acta|July 29, 1992
Isolation and characterization of two sub-species of Lp(a), one containing apo E and one free of apo EJ M Bard, S Delattre-Lestavel, V Clavey, et al.
Pageof 54

Showing results (391-400 of 538) with videos related to

Sort By:
Pageof 54
Circulation|February 24, 2001
PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophagesB P Neve, D Corseaux, G Chinetti, et al.
Metabolism: Clinical and Experimental|December 1, 1991
High-density lipoprotein particles in octogenariansG Luc, J M Bard, S Lussier-Cacan, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 14, 1990
Lipoprotein particles in homozygous familial hypercholesterolemic patients treated with portacaval shunt and LDL apheresisD Gairin, F Monard, C Cachera, et al.
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1991
[Liaison of apolipoprotein A with adipose cells: characteristics of the receptor sites and their role in the efflux of cholesterol]R Barbaras, P Puchois, A Pradines-Figuères, et al.
Presse Medicale (Paris, France : 1983)|December 17, 1988
[Type IIa dyslipoproteinemia. Effects of simvastatin and bezafibrate on atherogenic and non-atherogenic lipoprotein particles]J M Lecerf, J M Bard, V Leclerc, et al.
Clinical Chemistry|June 1, 1987
Electroimmunoassay for determination of ApoB in human sera by using a mixture of monoclonal antibodiesI Pruvot, C Fievet, J C Fruchart, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1987
Chemical approach to synthetic immunogens in clinical chemistryC Delpierre, C Martin, J C Gesquiere, et al.
Circulation Research|September 4, 1999
Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathwayP Delerive, F Martin-Nizard, G Chinetti, et al.
Revue D'Epidemiologie Et De Sante Publique|April 10, 2003
[Biological banks of the prospective cohort PRIME Study]G Luc, J Ferri res, A Evans, et al.
Biochimica Et Biophysica Acta|July 29, 1992
Isolation and characterization of two sub-species of Lp(a), one containing apo E and one free of apo EJ M Bard, S Delattre-Lestavel, V Clavey, et al.
Pageof 54